Abstract
Obsessive-compulsive disorder (OCD) is a common psychiatric disorder defined by the presence of obsessive thoughts and repetitive compulsive actions, and it often encompasses anxiety and depressive symptoms1,2. Recently, the corticostriatal circuitry has been implicated in the pathogenesis of OCD3,4. However, the etiology, pathophysiology and molecular basis of OCD remain unknown. Several studies indicate that the pathogenesis of OCD has a genetic component5,6,7,8. Here we demonstrate that loss of a neuron-specific transmembrane protein, SLIT and NTRK-like protein-5 (Slitrk5), leads to OCD-like behaviors in mice, which manifests as excessive self-grooming and increased anxiety-like behaviors, and is alleviated by the selective serotonin reuptake inhibitor fluoxetine. Slitrk5−/− mice show selective overactivation of the orbitofrontal cortex, abnormalities in striatal anatomy and cell morphology and alterations in glutamate receptor composition, which contribute to deficient corticostriatal neurotransmission. Thus, our studies identify Slitrk5 as an essential molecule at corticostriatal synapses and provide a new mouse model of OCD-like behaviors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Miguel, E.C. et al. Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol. Psychiatry 10, 258–275 (2005).
Karno, M., Golding, J.M., Sorenson, S.B. & Burnam, M.A. The epidemiology of obsessive-compulsive disorder in five US communities. Arch. Gen. Psychiatry 45, 1094–1099 (1988).
Graybiel, A.M. & Rauch, S.L. Toward a neurobiology of obsessive-compulsive disorder. Neuron 28, 343–347 (2000).
Menzies, L. et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci. Biobehav. Rev. 32, 525–549 (2008).
Clifford, C.A., Murray, R.M. & Fulker, D.W. Genetic and environmental influences on obsessional traits and symptoms. Psychol. Med. 14, 791–800 (1984).
Rasmussen, S.A. & Tsuang, M.T. The epidemiology of obsessive compulsive disorder. J. Clin. Psychiatry 45, 450–457 (1984).
Pauls, D.L., Alsobrook, J.P. II, Goodman, W., Rasmussen, S. & Leckman, J.F. A family study of obsessive-compulsive disorder. Am. J. Psychiatry 152, 76–84 (1995).
Nestadt, G. et al. A family study of obsessive-compulsive disorder. Arch. Gen. Psychiatry 57, 358–363 (2000).
Hollander, E., Kim, S., Khanna, S. & Pallanti, S. Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issues. CNS Spectr. 12, 5–13 (2007).
Abelson, J.F. et al. Sequence variants in SLITRK1 are associated with Tourette′s syndrome. Science 310, 317–320 (2005).
Aruga, J. & Mikoshiba, K. Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth. Mol. Cell. Neurosci. 24, 117–129 (2003).
Aruga, J., Yokota, N. & Mikoshiba, K. Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue. Gene 315, 87–94 (2003).
Katayama, K. et al. Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities. Mol. Psychiatry 15, 177–184 (2010).
Shmelkov, S.V., Visser, J.W. & Belyavsky, A.V. Two-dimensional gene expression fingerprinting. Anal. Biochem. 290, 26–35 (2001).
Milde, T. et al. A novel family of slitrk genes is expressed on hematopoietic stem cells and leukemias. Leukemia 21, 824–827 (2007).
Valenzuela, D.M. et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat. Biotechnol. 21, 652–659 (2003).
Welch, J.M. et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 448, 894–900 (2007).
McClung, C.A. et al. DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res. Mol. Brain Res. 132, 146–154 (2004).
Saxena, S., Bota, R.G. & Brody, A.L. Brain-behavior relationships in obsessive-compulsive disorder. Semin. Clin. Neuropsychiatry 6, 82–101 (2001).
Whiteside, S.P., Port, J.D. & Abramowitz, J.S. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res. 132, 69–79 (2004).
Saxena, S. & Rauch, S.L. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr. Clin. North Am. 23, 563–586 (2000).
Aylward, E.H. et al. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Arch. Gen. Psychiatry 53, 577–584 (1996).
Robinson, D. et al. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch. Gen. Psychiatry 52, 393–398 (1995).
Rosenberg, D.R. et al. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch. Gen. Psychiatry 54, 824–830 (1997).
Szeszko, P.R. et al. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am. J. Psychiatry 161, 1049–1056 (2004).
Surmeier, D.J., Ding, J., Day, M., Wang, Z. & Shen, W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 30, 228–235 (2007).
Rauch, S.L. et al. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol. Psychiatry 61, 330–336 (2007).
Wang, L., Simpson, H.B. & Dulawa, S.C. Assessing the validity of current mouse genetic models of obsessive-compulsive disorder. Behav. Pharmacol. 20, 119–133 (2009).
Joel, D. Current animal models of obsessive compulsive disorder: a critical review. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 374–388 (2006).
Rauch, S.L. Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders. Neurosurg. Clin. N. Am. 14, 213–223 vii–viii (2003).
Cattaneo, E. et al. Loss of normal huntingtin function: new developments in Huntington′s disease research. Trends Neurosci. 24, 182–188 (2001).
Deng, H., Le, W.D., Xie, W.J. & Jankovic, J. Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol. Scand. 114, 400–402 (2006).
Keen-Kim, D. et al. Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Hum. Mol. Genet. 15, 3324–3328 (2006).
Chen, Z.Y. et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314, 140–143 (2006).
Picconi, B. et al. Loss of bidirectional striatal synaptic plasticity in l-DOPA–induced dyskinesia. Nat. Neurosci. 6, 501–506 (2003).
Lovinger, D.M., Tyler, E.C. & Merritt, A. Short- and long-term synaptic depression in rat neostriatum. J. Neurophysiol. 70, 1937–1949 (1993).
Alger, B.E. & Teyler, T.J. Long-term and short-term plasticity in the CA1, CA3 and dentate regions of the rat hippocampal slice. Brain Res. 110, 463–480 (1976).
Pereira, D.B. & Chao, M.V. The tyrosine kinase Fyn determines the localization of TrkB receptors in lipid rafts. J. Neurosci. 27, 4859–4869 (2007).
Acknowledgements
We thank M. Flint Beal for providing expertise on behavioral experiments. We thank G. Thurston for critical comments and suggestions. PSD95-cherry was a kind gift from R.H. Edwards (University of California–San Francisco). We acknowledge support from US National Institutes of Health grants MH079513 (F.S.L.) and NS052819 (F.S.L.), HL66592 (S.R.), HL097797 (S.R.) and AI080309 (S.R.), Burroughs Wellcome Foundation (F.S.L.), International Mental Health Research Organization (F.S.L.), the Sackler Institute (K.G.B., F.S.L.), DeWitt-Wallace Fund of the New York Community Trust (F.S.L.), Pritzker Consortium (F.S.L.), National Alliance for Research on Schizophrenia and Depression (S.V.S.), Mildred-Scheel-Stiftung, Deutsche Krebshilfe (T.M.), Gulbenkian PhD Programe in Biomedicine (C.C.P.), Fundacao para Ciencia e Tecnologia (C.C.P.), Howard Hughes Medical Institute (S.R.), Ansary Stem Cell Institute (S.R.), Anbinder and Newmans Own Foundations (S.R.), Qatar National Priorities Research Program (S.R.), Empire State Stem Cell Board (S.R.) and the New York State Department of Health grant NYS C024180 (S.R.).
Author information
Authors and Affiliations
Contributions
S.V.S. conceived of and designed the study, performed experiments, analyzed data and wrote the manuscript; A.H., D.J, C.C.P. and K.G.B. designed and performed experiments, analyzed data and assisted in writing the manuscript; T.M., E.S., J.S.K., M.B. and I.D. performed experiments and analyzed data; A.J.M., D.M.V., N.W.G. and G.D.Y. designed and generated the Slitrk5−/− mice; I.N. designed, performed and analyzed electrophysiology experiments; F.S.L. and S.R. conceived of and designed the study and wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–9 and Supplementary Methods (PDF 854 kb)
Rights and permissions
About this article
Cite this article
Shmelkov, S., Hormigo, A., Jing, D. et al. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice. Nat Med 16, 598–602 (2010). https://doi.org/10.1038/nm.2125
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2125
This article is cited by
-
Persistent enhancement of basolateral amygdala-dorsomedial striatum synapses causes compulsive-like behaviors in mice
Nature Communications (2024)
-
The Sapap3−/− mouse reconsidered as a comorbid model expressing a spectrum of pathological repetitive behaviours
Translational Psychiatry (2023)
-
miR-377-3p Regulates Hippocampal Neurogenesis via the Zfp462-Pbx1 Pathway and Mediates Anxiety-Like Behaviors in Prenatal Hypoxic Offspring
Molecular Neurobiology (2023)
-
Corticostriatal Projections Relying on GABA Levels Mediate Exercise-Induced Functional Recovery in Cerebral Ischemic Mice
Molecular Neurobiology (2023)
-
The prefrontal cortex and OCD
Neuropsychopharmacology (2022)